The effect of plasma-derived activated protein C on leukocyte cell-death and vascular endothelial damage

Thrombosis Research

Volumn 135, Issue 5, 2015, Pages 963-969

  Iba, Toshiaki ^a   Nagakari, Kunihiko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Box 1; Group; High; Intravital microscope; Microcirculation; Mobility; Necrosis; Neutrophil extracellular traps; Nucleosome

Indexed keywords

ACTIVATED PROTEIN C; ALBUMIN; HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENDOTHELIUM LESION; ERYTHROCYTE; EXTRACELLULAR TRAP; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE ACTIVATION; MESENTERY BLOOD FLOW; MICROCIRCULATION; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; RAT; SEPSIS; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; IMMUNOLOGY; PATHOLOGY; WISTAR RAT;

ANIMALS; CELL DEATH; ENDOTHELIUM, VASCULAR; LEUKOCYTES; LIPOPOLYSACCHARIDES; MICROCIRCULATION; PROTEIN C; RATS, WISTAR; SEPSIS;

EID: 84928598822     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.03.012     Document Type: Article

References (40)

1. M. Levi, and T. van der Poll Recombinant human activated protein C: current insights into its mechanism of action Crit Care 11 2007 S3
2. W.L. Macias, S.B. Yan, M.D. Williams, S.L. Um, G.E. Sandusky, and D.W. Ballard New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated) Crit Care 9 2005 S38 S45
3. J.H. Griffin, B.V. Zlokovic, and L.O. Mosnier Protein C anticoagulant and cytoprotective pathways Int J Hematol 95 2012 333 345
4. E.A. Bouwens, F. Stavenuiter, and L.O. Mosnier Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway J Thromb Haemost 11 2013 242 253
5. C.J. Hemmer, M. Löbermann, M. Unverricht, A. Vogt, R. Krause, and E.C. Reisinger Activated protein C protects vascular endothelial cells from apoptosis in malaria and in sepsis Trop Med Int Health 16 2011 906 913
6. R.P. Dellinger, M.M. Levy, J.M. Carlet, J. Bion, M.M. Parker, and R. Jaeschke Surviving sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 Crit Care Med 36 2008 296 327
7. V.M. Ranieri, B.T. Thompson, P.S. Barie, J.F. Dhainaut, I.S. Douglas, and S. Finfer Drotrecogin alfa (activated) in adults with septic shock N Engl J Med 366 2012 2055 2064
8. A.C. Kalil, and S.P. LaRosa Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression Lancet Infect Dis 12 2012 678 686
9. E. Rimmer, A. Kumar, S. Doucette, J. Marshall, S. Dial, and D. Gurka Co-operative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Activated protein C and septic shock: a propensity-matched cohort study Crit Care Med 40 2012 2974 2981
10. S.C. Christiaans, B.M. Wagener, C.T. Esmon, and J.F. Pittet Protein C and acute inflammation: a clinical and biological perspective Am J Physiol Lung Cell Mol Physiol 305 2013 L455 L466
11. N. Aoki, T. Matsuda, H. Saito, K. Takatsuki, K. Okajima, and H. Takahashi A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation Int J Hematol 75 2002 540 547
12. T. Iba, T. Miki, N. Hashiguchi, Y. Tabe, and I. Nagaoka Is the neutrophil a 'prima donna' in the procoagulant process during sepsis? Crit Care 18 2014 230
13. T. Iba, A. Kidokoro, M. Fukunaga, S. Fuse, M. Suda, and S. Kunitada Factor Xa-inhibitor (DX-9065a) modulates the leukocyte-endothelial cell interaction in endotoxemic rat Shock 17 2002 159 162
14. T. Iba, T. Miki, N. Hashiguchi, Y. Tabe, and I. Nagaoka Activated protein C suppresses the production of pro-inflammatory cytokines and the leukocyte-endothelial interaction in rat LPS model J Jpn Soc Intensive Care Med 12 2005 191 195
15. W.J. Wiersinga, S.J. Leopold, D.R. Cranendonk, and T. van der Poll Host innate immune responses to sepsis Virulence 5 2014 36 44
16. T.A. Fuchs, U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, and V. Wahn Novel cell death program leads to neutrophil extracellular traps J Cell Biol 176 2007 231 241
17. S.R. Clark, A.C. Ma, S.A. Tavener, B. McDonald, Z. Goodarzi, and M.M. Kelly Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood Nat Med 13 2007 463 469
18. T.A. Fuchs, A.A. Bhandari, and D.D. Wagner Histones induce rapid and profound thrombocytopenia in mice Blood 118 2011 3708 3714
19. K. Kambas, I. Mitroulis, E. Apostolidou, A. Girod, A. Chrysanthopoulou, and I. Pneumatikos Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis PLoS One 7 2012 e45427
20. B. Steppich, I. Seitz, G. Busch, A. Stein, and I. Ott Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases Thromb Haemost 100 2008 1068 1075
21. T. Iba, A. Kidokoro, M. Fukunaga, K. Nagakari, A. Shirahama, and Y. Ida Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model Crit Care Med 33 2005 368 372
22. J.P. Miletich, and G.J. Broze Jr. Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites J Biol Chem 265 1990 11397 11404
23. P. Simioni, M. Kalafatis, D.S. Millar, S.C. Henderson, S. Luni, and D.N. Cooper Compound heterozygous protein C deficiency resulting in the presence of only the beta-form of protein C in plasma Blood 88 1996 2101 2108
24. E.J. Kerschen, J.A. Fernandez, B.C. Cooley, X.V. Yang, R. Sood, and L.O. Mosnier Endotoxemia and sepsis mortality reduction by nonanticoagulant-activated protein C J Exp Med 204 2007 2439 2448
25. C. Cao, Y. Gao, Y. Li, T.M. Antalis, F.J. Castellino, and L. Zhang The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b J Clin Invest 120 2010 1971 1980
26. L.M. Kager, M. Schouten, W.J. Wiersinga, J.D. de Boer, L.C. Lattenist, and J.J. Roelofs Overexpression of the endothelial protein C receptor is detrimental during pneumonia-derived gram-negative sepsis (Melioidosis) PLoS Negl Trop Dis 7 2013 e2306
27. D.H. Sturn, N.C. Kaneider, C. Feistritzer, A. Djanani, K. Fukudome, and C.J. Wiedermann Expression and function of the endothelial protein C receptor in human neutrophils Blood 102 2003 1499 1505
28. G.F. Elphick, P.P. Sarangi, Y.M. Hyun, J.A. Hollenbaugh, A. Ayala, and W.L. Biffl Recombinant human activated protein C inhibits integrin-mediated neutrophil migration Blood 113 2009 4078 4085
29. J.A. Nick, C.D. Coldren, M.W. Geraci, K.R. Poch, B.W. Fouty, and J. O'Brien Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis Blood 104 2004 3878 3885
30. B. Isermann, I.A. Vinnikov, T. Madhusudhan, S. Herzog, M. Kashif, and J. Blautzik Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis Nat Med 13 2007 1349 1358
31. J. Zhou, D. Pavlovic, J. Willecke, C. Friedel, S. Whynot, and O. Hung Activated protein C improves pial microcirculation in experimental endotoxemia in rats Microvasc Res 83 2012 276 280
32. J.N. Hoffmann, B. Vollmar, M.W. Laschke, D. Inthorn, J. Fertmann, and F.W. Schildberg Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia Crit Care Med 32 2004 1011 1017
33. H. Weiler Regulation of inflammation by the protein C system Crit Care Med 38 2010 S18 S25
34. N. Bir, M. Lafargue, M. Howard, A. Golaerts, J. Roux, and M. Carles Cytoprotective-selective activated protein C attenuates Pseudomonas aeruginosa-induced lung injury in mice Am J Respir Cell Mol Biol 45 2011 632 641
35. S.R. Coughlin Protease-activated receptors in hemostasis, thrombosis and vascular biology J Thromb Haemost 3 2005 1800 1814
36. M. Schouten, C. van't Veer, J.J. Roelofs, J.C. Meijers, M. Levi, and T. van der Poll Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study Crit Care 16 2012 R238
37. M. Magna, and D.S. Pisetsky The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases Mol Med 20 2014 138 146
38. M. Saffarzadeh, C. Juenemann, M.A. Queisser, G. Lochnit, G. Barreto, and S.P. Galuska Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones PLoS One 7 2012 e32366
39. J. Xu, X. Zhang, R. Pelayo, M. Monestier, C.T. Ammollo, and F. Semeraro Extracellular histones are major mediators of death in sepsis Nat Med 15 2009 1318 1321
40. M.R. Gillrie, K. Lee, D.C. Gowda, S.P. Davis, M. Monestier, and L. Cui Plasmodium falciparum histones induce endothelial proinflammatory response and barrier dysfunction Am J Pathol 180 2012 1028 1039